Clinical and radiographic findings

Youth

Adults

Seniors

Total

Chi-square

N (%)

N (%)

N (%)

N (%)

X² (P-value)

PeBL

MI

38 (61.3%)

46 (25.3%)

0 (0.0%)

84 (28.2%)

44.353 (<0.001**)

MO

22 (35.5%)

76 (41.8%)

20 (37.0%)

118 (39.6%)

S

2 (3.2%)

60 (33.0%)

34 (63.0%)

96 (32.2%)

>5MDP

N

54 (87.1%)

140 (76.9%)

18 (33.3%)

212 (71.1%)

22.533

(<0.001**)

P

8 (12.9%)

42 (23.1%)

36 (66.7%)

86 (28.9%)

TFO

N

56 (90.3%)

124 (68.1%)

36 (66.7%)

216 (72.5%)

7.330 (0.026*)

P

6 (9.7%)

58 (31.9%)

18 (33.3%)

82 (27.5%)

BC

N

62 (100.0%)

154 (84.6%)

36 (66.7%)

252 (84.6%)

16.089 (0.003**)

D

0 (0.0%)

22 (12.1%)

12 (22.2%)

34 (11.4%)

F

0 (0.0%)

6 (3.3%)

6 (11.1%)

12 (4.0%)

<20R

N

62 (100.0%)

164 (90.1%)

22 (40.7%)

248 (83.2%)

39.579 (<0.001**)

P

0 (0.0%)

18 (9.9%)

32 (59.3%)

50 (16.8%)

.PBL

H

54 (87.1%)

156 (85.7%)

46 (85.2%)

256 (85.9%)

0.051 (0.975)

V

8 (12.9%)

26 (14.3%)

8 (14.8%)

42 (14.1%)

TM

N

48 (77.4%)

82 (45.1%)

10 (18.5%)

140 (47.0%)

35.738 (<0.001**)

Gr I

12 (19.4%)

32 (17.6%)

6 (11.1%)

50 (16.8%)

Gr II

0 (0.0%)

28 (15.4%)

18 (33.3%)

46 (15.4%)

GrIII

2 (3.2%)

40 (22.0%)

20 (37.0%)

62 (20.8%)

FI

N

56 (90.3%)

92 (50.5%)

8 (14.8%)

156 (52.3%)

62.183

(<0.001**)

Gr I

6 (9.7%)

42 (23.1%)

8 (14.8%)

56 (18.8%)

Gr II

0 (0.0%)

24 (13.2%)

20 (37.0%)

44 (14.8%)

Gr III

0 (0.0%)

16 (8.8%)

0 (0.0%)

16 (5.4%)

Gr IV

0 (0.0%)

8 (4.4%)

18 (33.4%)

26 (8.7%)